Quest for better pancreatic cancer tests gains insights from survivor’s data

CA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit: Clinical Case Reports (2024). DOI: 10.1002/ccr3.8929 Patients with advanced cases of pancreatic cancer have a poor survival rate, and in the early stages the cancer does not usually produce any noticeable symptoms. Thus, the search for accurate blood tests for early and reliable screening is a high priority to increase survival, says Flinders University research fellow Dr. Jean Winter. “Our Read More

Leave a Reply

Your email address will not be published. Required fields are marked *